Franklin Templeton
Asset ManagementSan Mateo, United StatesSee on the mapfranklintempleton.com
Franklin Templeton is an investment manager offering investment solutions to individual, financial professional, and institutional investors.
- 2
- Portfolio companies on reccy
- 1
- Hiring now
- 12
- Open roles in the portfolio
- Nov 2023
- Latest portfolio round
Hiring now in the portfolio12
Apply on each company's site- Posted 5d ago
Senior Director, Data Management
Alto Neuroscience · Mountain View, CA
- Posted 24d ago
Senior Manager, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Senior Manager/Director of Contracts and Procurement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Manager, Patient Recruitment & Engagement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
VP, Commercial Planning
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Clinical Trial Associate
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Associate Director, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Manager, Clinical Science & Site Educator
Alto Neuroscience · Remote (US)
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- Alto NeuroscienceLos Altos, CA
- Jul 2026Post-IPO Equity (PIPE) · $100M
- Mar 2026Post-IPO Equity (PIPE) · $120M
- Oct 2025Post-IPO Equity (PIPE) · $50M
- Jul 2024Grant · $11.7M
- Nov 2023Venture Round · $59.3M
- Nov 2023Series C · $45MLed
- Ray TherapeuticsSan Diego, CA
Neuroscience research tools · Sensory restoration
- Sep 2026Grant · $8M
- Apr 2026Series B · $125M
- Apr 2025Grant · $8M
- Nov 2023Grant · $4M
- May 2023Series A · $100M
- Apr 2022Grant · $4M
Rounds marked Led list Franklin Templeton as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Nov 2023
Alto Neuroscience · Series C $45MLead
With InVivium Capital, Point72 Ventures, Eli Lilly and Company, Alexandria Venture Investments
Portfolio in the news
From the Cortex · last 12 months- Oct 2026
- Sep 2026